Adverse Events During Physiotherapy at Intensive Care Unit In Patients Undergoing Cardiac Surgery
NCT ID: NCT03552887
Last Updated: 2018-06-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
323 participants
OBSERVATIONAL
2016-06-01
2017-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pre-operative Physiotherapy to Prevent Post-operative Complications
NCT01389648
Assessment of Patients Undergoing Cardiac Surgery and Admitted to the Intensive Care Unit
NCT06154473
Contract-Relax (CR) Technique in the Management of Diaphragmatic Paresis After Cardiac Surgery
NCT05068219
Impact of Three Body Positioning Strategies in the Drainage Fluids After Coronary Artery Bypass Surgery
NCT02525289
Preoperative Evaluation of Microcirculation for Prediction of Complications After Cardiac Surgery
NCT03631797
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A prospective observational study of patients admitted at surgical ICU, aged \> 18 years old, undergoing cardiac surgery was conducted to estimate the incidence of adverse events during physiotherapy interventions in those patients and to identify predictors of adverse events.
Physiotherapy interventions were observed, performed by physiotherapists outside of the protocol. The occurrence of adverse events or physiological abnormality were recorded, classifying them according to the symptomatic consequences for the patient, from grade 1 ("near miss", additional intervention not required) to grade 5 (death). The investigators collected clinical characteristics of patients, such as sequential organ failure assessment (SOFA) score, comorbidities, sedation leve and pain. Participants were followed up to hospital discharge.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Postoperative patients
Cohort of patients undergoing cardiac surgery, aged ≥ 18 years old, who had received any physiotherapy intervention
Cardiac Surgery
Any type of cardiac surgery
Physiotherapy
Any type of physiotherapy intervention, performed by physiotherapists outside of the protocol
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cardiac Surgery
Any type of cardiac surgery
Physiotherapy
Any type of physiotherapy intervention, performed by physiotherapists outside of the protocol
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age ≥ 18 years old
* Patients who are receiving any physiotherapy intervention
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Sao Paulo General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Emilia Nozawa, PT PhD
Vice Director, Physiotherapy Department
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Emilia Nozawa, PhD, PT
Role: PRINCIPAL_INVESTIGATOR
Instituto do Coracao, Hospital das Clinicas, USP
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
51256215.5.0000.0068
Identifier Type: OTHER
Identifier Source: secondary_id
1391854
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.